JP2025026461A5 - - Google Patents

Info

Publication number
JP2025026461A5
JP2025026461A5 JP2024193753A JP2024193753A JP2025026461A5 JP 2025026461 A5 JP2025026461 A5 JP 2025026461A5 JP 2024193753 A JP2024193753 A JP 2024193753A JP 2024193753 A JP2024193753 A JP 2024193753A JP 2025026461 A5 JP2025026461 A5 JP 2025026461A5
Authority
JP
Japan
Prior art keywords
vaccine
animal
lawsonia intracellularis
immune response
protective immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024193753A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025026461A (ja
Filing date
Publication date
Priority claimed from JP2023504581A external-priority patent/JP7657287B2/ja
Application filed filed Critical
Publication of JP2025026461A publication Critical patent/JP2025026461A/ja
Publication of JP2025026461A5 publication Critical patent/JP2025026461A5/ja
Pending legal-status Critical Current

Links

JP2024193753A 2020-07-24 2024-11-05 組合せブタワクチン Pending JP2025026461A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US202063055947P 2020-07-24 2020-07-24
US63/055,947 2020-07-24
EP20196349.3 2020-09-16
EP20196349 2020-09-16
JP2023504581A JP7657287B2 (ja) 2020-07-24 2021-07-22 組合せブタワクチン
PCT/US2021/042778 WO2022020593A2 (en) 2020-07-24 2021-07-22 Combination porcine vaccine

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023504581A Division JP7657287B2 (ja) 2020-07-24 2021-07-22 組合せブタワクチン

Publications (2)

Publication Number Publication Date
JP2025026461A JP2025026461A (ja) 2025-02-21
JP2025026461A5 true JP2025026461A5 (https=) 2025-09-04

Family

ID=77274829

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023504581A Active JP7657287B2 (ja) 2020-07-24 2021-07-22 組合せブタワクチン
JP2024193753A Pending JP2025026461A (ja) 2020-07-24 2024-11-05 組合せブタワクチン

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2023504581A Active JP7657287B2 (ja) 2020-07-24 2021-07-22 組合せブタワクチン

Country Status (12)

Country Link
US (1) US20230241198A1 (https=)
EP (1) EP4185321A2 (https=)
JP (2) JP7657287B2 (https=)
KR (1) KR20230044474A (https=)
CN (1) CN116157147A (https=)
AU (1) AU2021311726A1 (https=)
BR (1) BR112023001324A2 (https=)
CA (1) CA3185751A1 (https=)
CL (1) CL2023000118A1 (https=)
CO (1) CO2023000299A2 (https=)
MX (1) MX2023001024A (https=)
WO (1) WO2022020593A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116036260A (zh) * 2022-12-30 2023-05-02 哈药集团生物疫苗有限公司 猪圆环病毒、猪肺炎支原体、猪塞内卡病毒三联灭活疫苗及其制备方法和应用
WO2024260953A1 (en) * 2023-06-23 2024-12-26 Intervet International B.V. A method of culturing lawsonia intracellularis bacteria
CN118477172A (zh) * 2024-01-09 2024-08-13 浙江鼎持生物制品有限公司 一种猪三联灭活疫苗及其制备方法
CN118894910B (zh) * 2024-07-24 2026-03-06 华南农业大学 一种PRRSV-GP3-GP5-M+PCV2-TBCap重组蛋白、疫苗及应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
EP0173552B1 (en) 1984-08-24 1991-10-09 The Upjohn Company Recombinant dna compounds and the expression of polypeptides such as tpa
JP3128133B2 (ja) 1991-06-06 2001-01-29 スティッチティング セントラール ディールゲネースクンディグ インスティトゥート 豚の奇病の原因体であるレリスタドエイジェント、それを含むワクチン組成物、豚の奇病の診断キット及び診断方法
US6042830A (en) 1992-08-05 2000-03-28 Boehringer Ingelheim Vetmedica, Inc. Viral agent associated with mystery swine disease
DK0601062T4 (da) 1991-08-26 2001-03-14 Univ Minnesota SIRS-vaccine og diagnosefremgangsmåde
AU2696792A (en) 1991-09-16 1993-04-27 David A Benfield Vaccine for mystery swine disease and method for diagnosis thereof
AU2684792A (en) 1991-10-14 1993-05-21 Akzo Nobel N.V. Porcine reproductive respiratory syndrome vaccine and diagnostic
DE69522984T2 (de) 1994-04-11 2002-04-25 Akzo Nobel Nv Europäische Vakzinstämme des Fortplanzungs-Atmungs-Syndromsvirus des Schweins
US5788962A (en) 1995-01-17 1998-08-04 The Curators Of The University Of Missouri DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures
EP0732340B1 (en) 1995-03-14 2004-06-09 Akzo Nobel N.V. Expression of porcine reproductive respiratory syndrome virus polypeptides in the same cell
US5885823A (en) 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
EP0835930B1 (en) 1996-10-09 2001-01-31 Akzo Nobel N.V. European vaccine strains of the porcine reproductive and respiratory syndrome virus (PRRSV)
US6517843B1 (en) 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
UA78180C2 (uk) 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
US6391314B1 (en) 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
US6943152B1 (en) 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
DE602004023094D1 (de) 2003-07-25 2009-10-22 Boehringer Ingelheim Vetmed Lawsonia intracellularis europäischen ursprungs unür
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
DK3766518T3 (da) 2005-12-29 2026-04-13 Boehringer Ingelheim Animal Health Usa Inc Immunogen pcv2-sammensætning til mindskelse af kliniske symptomer hos grise
EP3868400A1 (en) * 2005-12-29 2021-08-25 Boehringer Ingelheim Animal Health USA Inc. Multivalent pcv2 immunogenic compositions and methods of producing such compositions
PT2094872T (pt) 2006-12-15 2017-04-27 Boehringer Ingelheim Vetmedica Inc Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2
KR20100113582A (ko) 2008-01-23 2010-10-21 베링거잉겔하임베트메디카인코퍼레이티드 Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
US8444989B1 (en) 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
PH12013501708B1 (en) 2011-02-17 2018-08-03 Boehringer Ingelheim Vetmedica Gmbh Commercial scale process for production of prrsv
HRP20151031T1 (hr) 2011-02-17 2015-11-06 Boehringer Ingelheim Vetmedica Gmbh Novi europski soj prrsv
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
AR097762A1 (es) * 2013-09-27 2016-04-13 Intervet Int Bv Formulaciones secas de vacunas que son estables a temperatura ambiente
TWI670085B (zh) * 2014-02-19 2019-09-01 荷蘭商英特威國際公司 液體穩定之豬病毒疫苗

Similar Documents

Publication Publication Date Title
JP2025026461A5 (https=)
CN101175509B (zh) 含有胞内劳森菌的免疫原性组合物
JP5257901B2 (ja) ローソニア・イントラセルラリス感染に対する幼若動物のワクチン接種
Shewen et al. Challenges in mucosal vaccination of cattle
AU2013370982C9 (en) Immunogenic composition comprising mycoplasma antigens
JP2010510197A (ja) ワクチンの製造のためのクロストリジウム・パーフリンジェンスｃ型細菌の使用
US10188715B2 (en) Swine dysentery vaccine
Shin et al. Effective methods for the production of immunoglobulin Y using immunogens of Bordetella bronchiseptica, Pasteurella multocida and Actinobacillus pleuropneumoniae
JP2021535138A (ja) 混合ワクチン
Abodalal et al. Preparation of locally prepared inactivated combined vaccine of rabbit hemorrhagic disease virus types 1 & 2 and Pasteurella multocida.
Sun et al. Effect of four adjuvants on immune response to F4 fimbriae in chickens
Van den Broeck et al. Seroprevalence of F4+ enterotoxigenic Escherichia coli in regions with different pig farm densities
CN101541343B (zh) C型产气荚膜梭菌用于制备疫苗的用途
JP7349366B2 (ja) クロストリジウム類毒素を含むワクチン
Sturbelle et al. The use of quorum sensing to improve vaccine immune response
Smith The immunity produced by a rough Salmonella dublin variant against Salmonella typhimurium and Salmonella choleraesuis infection in guinea-pigs
Zyan et al. Field trial to evaluate the efficacy of aluminium hydroxide gel (Alv) rabbit pasteurella vaccine in rabbits
El-Sayed et al. Efficacy of the E. Coli whole cell lysates for improving immunogenic quality of the local entero-3 vaccine
Elsheikha et al. Therapeutic efficacy of chicken egg yolk immunoglobulins against Mycoplasma gallisepticum infection in chickens
Done Enteric and respiratory diseases in the young weaned piglet.
CALVES JS Cullor, B. Fenwick, BP Smith, K. Pelzer, A. Kelly, and BI Osburn Department of Veterinary Pathology
Jaber et al. Comparative efficacy of fowl cholera vaccines in ducks
Kaeberle et al. Pasteurella Vaccination of Ewes
DAOUD et al. PRODUCTION AND EVALUATION OF A NEWLY ADJUVANTED RABBIT PASTEURELLOSIS VACCINE
Ruggeri et al. Efficacy of an immunization protocol based on an attenuated Salmonella Typhimurium vaccine boosted with an inactivated Salmonella Choleraesuis vaccine in piglets experimentally infected with S. Choleraesuis.